ABOUT
The inability of the central nervous system (CNS) to regenerate has been attributed to several factors: First, the natural formation of cellular “bridges” essential for axonal regeneration does not occur at the site of injury. Second, the injured CNS fails to produce growth factors necessary to stimulate regeneration. Third, neurons in the injured CNS do not adequately initiate a “growth program” necessary for new regeneration. Finally, the environment of the injured adult spinal cord presents obstacles to regeneration, specifically due to inhibitory extracellular matrix molecules that accumulate around the injury site and the presence of inhibitory proteins in adult myelin that hinder regeneration.
We are committed to elucidating the molecular processes underlying neuronal regeneration and using these insights to develop practical strategies for repairing damaged CNS circuits.
Our research covers a broad spectrum from the identification of ECM molecules that impede axon regeneration to the development and application of advanced biomimetic materials in spinal cord injury (SCI) models.
Our group is interested in elucidating the molecular mechanisms governing regenerative failure after central nervous system injury and leveraging this knowledge to develop rationally tuned biomaterial strategies to reverse paralysis. Our goal is to translate these findings to humans.
RESEARCH FOCUS
Understanding the Barriers to Regeneration:
The primary focus of this research is to understand the role of the extracellular matrix (ECM) in spinal cord injury and regeneration.
Using quantitative mass spectrometry proteomics, our team is characterizing the ECM and ECM-associated proteome in spinal cords across developmental stages and injury conditions. This approach allows the identification of specific ECM components that change after injury, providing insight into potential therapeutic targets.
The comprehensive proteomic profile is further enhanced by transcriptomic profiling to identify soluble components, cellular contributors, and spatial information. This in-depth analysis of the ECM in both healthy and injured states aims to unravel the complex interactions and changes that occur and to guide the development of strategies to modulate the ECM to promote regeneration
Human spinal motor neurons grown on artificial matrix. SEM image of neurons interacting through their growth cones. Cells are falsely colored in green and purple.
New tools to study injury and regeneration in vitro:
This research area uses cutting-edge bioengineering methods and three-dimensional systems to mimic spinal cord structures and analyze their responses to injury in the laboratory. It uses two primary techniques:
1. Human Spinal Cord Organoids (hSCOs): hSCOs are generated using 3D printed organoid-on-a-chip technology, which creates a tubular shape that mimics the geometry of the spinal cord. This structure allows us to study how the shape of the tissue affects cellular organization within the organoids. In addition, by incorporating ECM signals at specific times after spinal cord injury, the study aims to explore the evolving nature of spinal cord injury and evaluate treatments based on ECM components identified through this research.
2. 3D printed human spinal cord constructs: This method combines two sophisticated printing technologies – cell bioprinting and volumetric printing – to produce a detailed, four-dimensional model of the human spinal cord with precise accuracy. The focus is on faithfully reproducing the white and gray matter of the spinal cord. It uses an exoskeletal framework to strategically place each bioprinted cell, closely mimicking the architecture of the spinal cord. This approach is designed to provide insight into the dynamic functional behavior of the spinal cord in vitro.
Translational Strategies for the Treatment of Spinal Cord Injury:
The third area of our research focuses on the development of innovative and effective biomaterial-based therapies for spinal cord injury (SCI) using in vivo models. Our team is implementing two different approaches depending on the stage of injury:
1. Injectable functionalized synthetic hydrogels for acute injury: We are creating chemically defined hydrogels that mimic various ECM signals, specifically tailored to treat the early stages of spinal cord injury. The goal is to study their impact on factors such as inflammation, cell survival, blood vessel formation, glial scar formation, and nerve fiber regeneration
2. 3D printed spinal cord constructs for chronic injury: For more advanced chronic spinal cord injuries, we are developing artificial 3D constructs embedded with ECM signals and living cells. These constructs are designed to provide nutritional support, promote neural growth, and support the functional development of native cells in nearby tissues. The primary goal is to enhance the integration, maturation, and connectivity of transplanted cells, which is critical for restoring motor function in models of chronic spinal cord injury.
HIGHLIGHTS
Expanding Our Capabilities in 3D Bioprinting
We are pleased to share that our lab has incorporated a new Volumetric Bioprinter, currently unique in Spain, with support from the ERC Consolidator Grant. Our team has already followed hands-on training delivered by the Readily 3D team and printed the first structures, including the logo of the lab! The printer will be dedicated to scaffold fabrication to build more advanced spinal cord models and accelerate our research.
STAFF
Staff members
ibecbarcelona.euPROJECTS
Projects as Principal Investigator
ERC-CoG (European Research Council)
Engineered Humanized Spinal Cord Constructs for Advanced Regeneration
Project code: ERC-COG-2025-101230979
Period: 2026–2031
CaixaHealth (La Caixa Foundation)
Human Vascularized Spinal Cord Organoid Device for Drug Discovery after Traumatic Injury
Project code: HR25-00406
Period: 2025–2028
Generación de Conocimiento (Ministerio de Ciencia, Innovación y Universidades)
In vivo Models of Humanized Spinal Cord Injury
Project code: PID2024-162574OB-I00
Period: 2025–2028
International Foundation for Research in Paraplegia (IFRP)
Human Vascularized Spinal Cord Organoids
Period: 2024–2026
R01 Grant NIH (National Institutes of Health)
Refining iPSC-Based Spinal Cord Model Systems by Fabricating Developmentally Programmed Extracellular Matrix Cues
Project code: R01 AG086270
Period: 2024–2029
Competitive Fellowships and Grants Obtained for Supervised Researchers
INPhINIT (La Caixa Foundation)
Recipient: Alexiane Touzé
Period: 2026–2029
Juan de la Cierva (Ministerio de Ciencia, Innovación y Universidades)
Code: JDC2023-051798
Recipient: Xavier Barceló
Period: 2024–2026
FPI (Ministerio de Ciencia, Innovación y Universidades)
Code: PRE2022-101803
Recipient: Palash Chavandranshi
Period: 2023–2027
IBEC Master Fellowship
Recipient: Anton Fornies
Period: 2023–2024
FI-STEP (AGAUR Generalitat de Catalunya)
Code: 2025 STEP 00182
Recipient: Rita Grimalt
Period: 2022–2025
PUBLICATIONS
Check for more detailed information on the outputs of the Group at IBEC CRIS portal.
Publications list:
EQUIPMENT
3D PRINTING
- Bio II Advance PLUS 3. Biological Safety Cabinet (TELSTAR)
- Anycubic Photon mono 4k + curing station (ANYCUBIC)
- Anycubic Photon M3 Premium + curing station (ANYCUBIC)
- Original Prusa Mini+ (PRUSA)
- LUMEN X Gen 3 3D Bioprinter (Lumenex)
- Volumetric 3D printer Tomolite v2.0 (Readily3D)
- R-GEN 200 BIOPRINTER (RegenHU)
- Microelectrode array (MEA) Maestro Pro (AXION Biosystem)
- IMARIS WORK STATION
ANIMAL FACILITY
- IH-0415 Infinite Horizon IMPACTOR Mouse/Rat
- DigiGait Imaging System – Mouse Only with Incline
- WPI Stereotaxic for mice, Digi and Portable, SGL M
COLLABORATIONS
- Samuel I. Stupp (Simpson Querrey Institute, Northwestern University)
- Aitziber López Cortajarena (CICbiomagune)
- Juan Alberto Ortega (Universitat de Barcelona)
- Evangelos Kiskinis (Northwestern University)
- Ivan R. Sasselli (CSIC)
- Elena Sanchez Lopez (Universitat de Barcelona)
- Riccardo Levato (Utrect University)
- Simone Di Giovani (Imperial College)
- Antonio Oliviero (Hospital Nacional de Parapléjicos de Toledo)
NEWS
LA VANGUARDIA: ¿Estudiar lesiones medulares sin recurrir a la experimentación animal?
El proyecto utilizará organoides creados a partir de células madre para reproducir lesiones medulares en condiciones similares a las humanas.
IBEC makes its mark at TERMISEU 2026 with a strong scientific presence and a key role in the conference’s leadership
From 21 to 24 April 2026, IBEC had a significant presence at TERMISEU 2026, the leading European conference on tissue engineering and regenerative medicine. Held at the Palma Conference Centre in Mallorca, the event brought together more than 1,600 researchers.
Barcelona hosts the fourth edition of the EMBL-IBEC Conference
The fourth EMBL-IBEC Conference, organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL), focused on disease modelling, developmental biology, and regenerative medicine. The event brought around 130 international bioengineering experts together at the PRBB in Barcelona this week.
BUSINESS INSIDER: Científicos españoles desarrollarán un nuevo modelo humano que promete mejores tratamientos para lesiones medulares
Tras el fracaso del 95% de los tratamientos probados en animales, este proyecto innovador está generado a partir de células madre humanas. Liderado por la investigadora Zaida Álvarez, del Instituto de Bioingeneria de Catalunya (IBEC), este nuevo modelo ha recibido cerca de un millón de euros de la Fundación “la Caixa” en la convocatoria de Investigación en Salud 2025.
Zaida Álvarez awarded a prestigious European ERC Consolidator Grant
The researcher at the Institute for Bioengineering of Catalonia has been awarded an ERC Consolidator Grant. This prestigious European funding supports excellent scientists and scholars who are consolidating their independent research teams to pursue their most promising scientific ideas. The €2.8 million SPINECRAFT grant, awarded for five years, will enable Álvarez and her team to build a high-fidelity, 4D human spinal cord model using advanced bioprinting and patient-derived cells. This platform aims to transform the study of spinal cord biology, neurodegenerative disorders, and regenerative therapies, setting the stage for breakthroughs previously out of reach.
IBEC receives funding from the ‘la Caixa’ Foundation’s Health Research 2025 Call to study new treatments for spinal cord injuries
Zaida Álvarez Pinto, a Principal Investigator at IBEC, will lead a biomedical research project that was selected in the 2025 edition of the ‘la Caixa’ Foundation’s Health Research Call for Proposals. The project, which will be carried out in consortium with IDIBELL, the University of Barcelona, the National Spinal Cord Injury Hospital Foundation and the Spinal Cord Injury Foundation, will focus on the development of a new platform for testing treatments for spinal cord injuries.
Bioengineering for precision medicine at the 18th IBEC Symposium
The 18th annual IBEC Symposium focused on ‘Bioengineering for Precision Medicine’, which is one of IBEC’s key areas of application. The event was attended by nearly 300 people, including local and international researchers. The multidisciplinary environment provided experts from other centres and the IBEC community with the opportunity to present their projects and exchange knowledge.
IBEC and SEMIT host the first SEMIT Congress in Barcelona
The Institute for Bioengineering of Catalonia (IBEC) and the Spanish Society of Regenerative Medicine and Tissue Engineering (SEMIT) organized the inaugural SEMIT 2025 Congress. The event gathered leading national and international experts in regenerative medicine and tissue engineering, creating a unique platform for knowledge exchange among researchers, clinicians, and industry.
Seven additional IBEC labs achieve top-level in My Green Lab certification
Seven more research groups at the Institute for Bioengineering of Catalonia (IBEC) have been certified by My Green Lab, reaching the highest rating, the Green Level, for sustainable laboratory practices. With these additions, IBEC core facilities and 70% of the Institute’s laboratories are now certified.
Sugar-coated nanotherapy dramatically improves neuron survival in Neurodegenerative model
The new therapy, made of nanofibers and trehalose, a sugar that naturally occurs in plants, traps and neutralizes toxic proteins to stop disease progression. Now trapped, the toxic proteins can no longer enter neurons and instead harmlessly degrade. The study, published in the journal of the American Society, was led by the Institute for Bioengineering of Catalonia and the Northwestern University.
IBEC receives funding from the US National Institutes of Health to advance neural regeneration
IBEC principal investigator Zaida Álvarez has received funding from the US National Institutes of Health (NIH) to develop stem cell-based models of the spinal cord. The project, coordinated by Northwestern University with the participation of IBEC and IDIBELL, will make it possible to study neurodegenerative diseases and develop new treatments for spinal cord injuries and other neurodegenerative pathologies.
Spinal cord organoids to study treatments for paraplegia
Se trata de un proyecto centrado en la creación de un dispositivo impreso en 3D donde se cultivará un organoide de médula espinal humana para estudiar el daño medular y el posterior testeo de fármacos. La investigación, liderada por la investigadora principal del IBEC Zaida Álvarez, ha recibido financiación de la Fundación Internacional para la Investigación de la Paraplejia.
IBEC is strengthened by the addition of three new research groups in advanced and emerging therapies
IBEC kicks off 2024 with the incorporation of three new research groups led by Manuel Salmerón Sánchez, Zaida Álvarez Pinto, and Xavier Rovira Clavé. With these additions, IBEC strengthens its position in the field of advanced and emerging therapies.
IBEC researchers highlight the role of women in science in different media
Coinciding with the celebration of 11 February, the Day of Girls and Women in Science, Nuria Montserrat is one of the three protagonists of the Constantes y Vitales campaign entitled … Read more
Scientists obtain mature neurons from stem cells in the lab to improve the study of neurodegenerative diseases
IBEC researcher Zaida Álvarez and UB researcher Alberto Ortega have produced the first highly mature neurons grown in the lab from pluripotent stem cells using a synthetic matrix. Until now, … Read more
Researchers manage to grow mature neurons at the lab to study neurogenerative diseases
Researches from the Institute for Bioengineering of Catalonia (IBEC) and the University of Barcelona (UB) have achieved the creation of the first highly mature neurones from human induced pluripotent stem … Read more
JOBS
Research in Training at the Biomaterials for Neural Regeneration Research Group
RT-ZA // Deadline: 05/07/2026
Researcher in Training at the Biomaterials for neural Regeneration Research Group
Ref: RT – ZA // Deadline: 6/04/2026
Postdoctoral Researcher at the Biomaterials for Neural Regeneration Research Group
Ref: ERC-CoG-SPINECRAFT-Postdoc-Neuro // Deadline: 20/02/2026
Predoctoral at the Biomaterials for Neural Regeneration Research Group
Ref: ERC-CoG-SPINECRAFT-PhD // Deadline: 20/02/2026
Technical Support to Research (Bioinformatician) at the Biomaterials For Neural Regeneration Research Group
Ref: GC-Bioinformatician // Deadline: 30/01/2026
PhD at the Biomaterials for Neural Regeneration Research Group
Ref: PhD-ZA // Deadline: 04/11/2025
Researcher in Training for Neural Regeneration Research Group
Ref: RT-ZA // Deadline: 12/03/2025
PhD at the Biomaterials for Neural Regeneration Research Group
Ref: PHD_ZA // Deadline: 10/03/2025
Research Assistant at the Biomaterials for Neural Regeneration Research Group
Ref: (RA_ZA)// Deadline: 30/10/2024
Laboratory technician at the Biomaterials for neural regeneration (LT_ZA)
Ref: LT_ZA // Deadline: 22/03/2023